BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17148579)

  • 1. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.
    Bomben R; Dal Bo M; Capello D; Benedetti D; Marconi D; Zucchetto A; Forconi F; Maffei R; Ghia EM; Laurenti L; Bulian P; Del Principe MI; Palermo G; Thorsélius M; Degan M; Campanini R; Guarini A; Del Poeta G; Rosenquist R; Efremov DG; Marasca R; Foà R; Gaidano G; Gattei V
    Blood; 2007 Apr; 109(7):2989-98. PubMed ID: 17148579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
    Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
    Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.
    Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stella S; Guida G; Michel A; Crespo M; Laoutaris N; Montserrat E; Anagnostopoulos A; Dighiero G; Fassas A; Caligaris-Cappio F; Davi F
    Blood; 2005 Feb; 105(4):1678-85. PubMed ID: 15466924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
    Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
    Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
    Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
    Stanganelli C; Travella A; Bezares R; Slavutsky I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.
    Stamatopoulos K; Belessi C; Moreno C; Boudjograh M; Guida G; Smilevska T; Belhoul L; Stella S; Stavroyianni N; Crespo M; Hadzidimitriou A; Sutton L; Bosch F; Laoutaris N; Anagnostopoulos A; Montserrat E; Fassas A; Dighiero G; Caligaris-Cappio F; Merle-Béral H; Ghia P; Davi F
    Blood; 2007 Jan; 109(1):259-70. PubMed ID: 16985177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.
    Thorsélius M; Kröber A; Murray F; Thunberg U; Tobin G; Bühler A; Kienle D; Albesiano E; Maffei R; Dao-Ung LP; Wiley J; Vilpo J; Laurell A; Merup M; Roos G; Karlsson K; Chiorazzi N; Marasca R; Döhner H; Stilgenbauer S; Rosenquist R
    Blood; 2006 Apr; 107(7):2889-94. PubMed ID: 16317103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin genes and chronic lymphocytic leukemia (CLL).
    Tobin G
    Ups J Med Sci; 2005; 110(2):97-113. PubMed ID: 16075892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.
    Ghia EM; Jain S; Widhopf GF; Rassenti LZ; Keating MJ; Wierda WG; Gribben JG; Brown JR; Rai KR; Byrd JC; Kay NE; Greaves AW; Kipps TJ
    Blood; 2008 May; 111(10):5101-8. PubMed ID: 18326815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
    Baliakas P; Agathangelidis A; Hadzidimitriou A; Sutton LA; Minga E; Tsanousa A; Scarfò L; Davis Z; Yan XJ; Shanafelt T; Plevova K; Sandberg Y; Vojdeman FJ; Boudjogra M; Tzenou T; Chatzouli M; Chu CC; Veronese S; Gardiner A; Mansouri L; Smedby KE; Pedersen LB; Moreno D; Van Lom K; Giudicelli V; Francova HS; Nguyen-Khac F; Panagiotidis P; Juliusson G; Angelis L; Anagnostopoulos A; Lefranc MP; Facco M; Trentin L; Catherwood M; Montillo M; Geisler CH; Langerak AW; Pospisilova S; Chiorazzi N; Oscier D; Jelinek DF; Darzentas N; Belessi C; Davi F; Ghia P; Rosenquist R; Stamatopoulos K
    Blood; 2015 Jan; 125(5):856-9. PubMed ID: 25634617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
    Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
    Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemia.
    Cahill N; Sutton LA; Jansson M; Murray F; Mansouri L; Gunnarsson R; Ryan F; Smedby KE; Geisler C; Juliusson G; Rosenquist R
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):201-6. PubMed ID: 22464020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.
    Matolcsy A; Casali P; Nádor RG; Liu YF; Knowles DM
    Blood; 1997 Mar; 89(5):1732-9. PubMed ID: 9057657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
    Schettino EW; Cerutti A; Chiorazzi N; Casali P
    J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
    Raponi S; Ilari C; Della Starza I; Cappelli LV; Cafforio L; Piciocchi A; Arena V; Mariglia P; Mauro FR; Gentile M; Cutrona G; Moia R; Favini C; Morabito F; Rossi D; Gaidano G; Guarini A; Del Giudice I; Foà R
    Br J Haematol; 2020 Jun; 189(5):853-859. PubMed ID: 32064595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.